Michael Weller

Also affiliated with University Hospital of Zurich

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 39 papers. Top paper: “A prognostic neural epigenetic signature in high-grade glioma”.

A prognostic neural epigenetic signature in high-grade glioma

Nature Medicine(2024)10.1038/s41591-024-02969-w

N/A

1.9DataRank · unranked

116 citations

Robin Khatri, Thomas Sauvigny, Malte Mohme, Cécile L. Maire, Alice Ryba +41 more

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

The Lancet Oncology(2009)10.1016/s1470-2045(09)70025-7

N/A

1.3DataRank · unranked

7738 citations

Monika E. Hegi, Martin J. van den Bent, Martin JB Taphoorn, Robert C. Janzer, Samuel K. Ludwin +25 more

MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma

New England Journal of Medicine(2005)10.1056/nejmoa043331

N/A

1.3DataRank · unranked

7181 citations

Annie-Claire Diserens, Thierry Gorlia, Marie-France Hamou, Nicolas de Tribolet, Michael Weller +15 more

A Neuroradiologist’s Guide to Operationalizing the Response Assessment in Neuro-Oncology (RANO) Criteria Version 2.0 for Gliomas in Adults

American Journal of Neuroradiology(2024)10.3174/ajnr.a8396

N/A

0.533DataRank · unranked

34 citations

Francesco Sanvito, Timothy F. Cloughesy, Raymond Y. Huang, Javier Villanueva-Meyer, Whitney B. Pope +21 more

Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: A report of the RANO resect group

Neuro-Oncology(2024)10.1093/neuonc/noae231

N/A

0.434DataRank · unranked

17 citations

Jacob S. Young, Gilbert C Youssef, Antonio Dono, Levin Häni, Tommaso Sciortino +25 more

Glioma patient-reported outcome assessment in clinical care and research: a Response Assessment in Neuro-Oncology collaborative report

The Lancet Oncology(2020)10.1016/s1470-2045(19)30796-x

N/A

0DataRank · unranked

81 citations

Linda Dirven, David Arons, Amanda Bates, Susan M. Chang, Corneel Coens +12 more

Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients

Neuro-Oncology(2020)10.1093/neuonc/noaa015

N/A

0DataRank · unranked

41 citations

Michael Weller, Joohee Sul, Stephen Bagley, Solmaz Sahebjam, Martin J. van den Bent +19 more

Estimated clinical efficacy and radiographic response characteristics of PD1 inhibition in newly diagnosed and recurrent glioblastoma in clinical practice: A report from the iRANO Working Group.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2521

N/A

0DataRank · unranked

4 citations

Raymond Y. Huang, Javier Villanueva‐Meyer, Mary Jane Lim-Fat, Elizabeth George, Bryan Iorgulescu +13 more

Evidence-based recommendations on categories for extent of resection in diffuse glioma

European Journal of Cancer(2021)10.1016/j.ejca.2021.03.002

N/A

0DataRank · unranked

209 citations

Michael A. Vogelbaum, Martin J. van den Bent, Daniel P. Cahill, Lorenzo Bello, Yoshitaka Narita +4 more

Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression

ACS Central Science(2021)10.1021/acscentsci.1c00070

N/A

0DataRank · unranked

63 citations

Ruth A. Pumroy, Charlotte Baker, Tiago Rodrigues, Ana Guerreiro, Bárbara B. Sousa +25 more

The epigenetic evolution of gliomas is determined by their IDH1 mutation status and treatment regimen

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.09.455687

N/A

0DataRank · unranked

2 citations

Thaís S. Sabedot, Indrani Datta, Luciano Garofano, Wies Vallentgoed, Frederick S. Varn +35 more

Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.03.442486

N/A

0DataRank · unranked

14 citations

Kevin C. Johnson, Taylor Wade, Tathiane M. Malta, Thaís S. Sabedot, Floris P Barthel +26 more

Glioma progression is shaped by genetic evolution and microenvironment interactions

Cell(2022)10.1016/j.cell.2022.04.038

N/A

0DataRank · unranked

506 citations

Kevin C. Johnson, Jan Martinek, Jason T. Huse, MacLean P. Nasrallah, Pieter Wesseling +53 more

Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions

Neuro-Oncology(2022)10.1093/neuonc/noac118

N/A

0DataRank · unranked

194 citations

Nayan Lamba, Manmeet S. Ahluwalia, Kenneth Aldape, Adrienne Boire, Priscilla K. Brastianos +20 more

EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors

Neuro-Oncology(2022)10.1093/neuonc/noac188

N/A

0DataRank · unranked

70 citations

David Capper, Adam Waldman, Johan Pallud, Giuseppe Minniti, Thomas Kaley +15 more

The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers

Acta Neuropathologica(2022)10.1007/s00401-022-02506-4

N/A

0DataRank · unranked

33 citations

Shahbaz Khan, Julie Livingstone, Kui Zhai, Dillon McKenna, Vladimir Ignatchenko +23 more

Hypothetical generalized framework for a new imaging endpoint of therapeutic activity in early phase clinical trials in brain tumors

Neuro-Oncology(2022)10.1093/neuonc/noac086

N/A

0DataRank · unranked

23 citations

Elizabeth R. Gerstner, Andrew B. Lassman, Caroline Chung, Howard Colman, Patricia E. Cole +21 more

Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management

Neuro-Oncology(2023)10.1093/neuonc/noad154

N/A

0DataRank · unranked

99 citations

Steven Tobochnik, Sara K. Inati, Johan A F Koekkoek, Guy M. McKhann, James J. Riviello +7 more

Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours

Nature Reviews Clinical Oncology(2023)10.1038/s41571-023-00756-z

N/A

0DataRank · unranked

93 citations

Rupert Bartsch, Émilie Le Rhun, Anna S. Berghoff, Priscilla K. Brastianos, Javier Cortés +8 more

The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen

Cancer Research(2023)10.1158/0008-5472.can-23-2093

N/A

0DataRank · unranked

57 citations

Thaís S. Sabedot, Natalia S. Morosini, Indrani Datta, Luciano Garofano, Wies Vallentgoed +67 more

Correcting the drug development paradigm for glioblastoma requires serial tissue sampling

Nature Medicine(2023)10.1038/s41591-023-02464-8

N/A

0DataRank · unranked

54 citations

Kelly Hotchkiss, Ian F. Parney, John de Groot, Solmaz Sahebjam, Nader Sanai +31 more

Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival

Neuro-Oncology(2023)10.1093/neuonc/noad002

N/A

0DataRank · unranked

46 citations

Patrick Y. Wen, Susan M. Chang, Martin J. van den Bent, Michael A. Vogelbaum, Gang Li +11 more

Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas

Cell Reports Medicine(2023)10.1016/j.xcrm.2023.101082

N/A

0DataRank · unranked

6 citations

Lluı́s Espinosa, Hyunsoo Kim, Denise Scholtens, Joseph P. McElroy, Rajani Rajbhandari +34 more

Epigenetic neural glioblastoma enhances synaptic integration and predicts therapeutic vulnerability

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.04.552017

N/A

0DataRank · unranked

8 citations

Robin Khatri, Thomas Sauvigny, Malte Mohme, Cécile L. Maire, Alice Ryba +37 more

Integrative spatial analysis reveals a multi-layered organization of glioblastoma

Cell(2024)10.1016/j.cell.2024.03.029

N/A

0DataRank · unranked

327 citations

Noam Galili Darnell, Rouven Hoefflin, Dor Simkin, Christopher Mount, L. Nicolas Gonzalez Castro +18 more

Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions

Neuro-Oncology(2024)10.1093/neuonc/noae103

N/A

0DataRank · unranked

61 citations

Ugonma Chukwueke, Myung‐Ju Ahn, Ayal A. Aizer, Tejus Bale, Dieta Brandsma +24 more

A brave new framework for glioma drug development

The Lancet Oncology(2024)10.1016/s1470-2045(24)00190-6

N/A

0DataRank · unranked

26 citations

Philipp Karschnia, Karisa C. Schreck, Marjolein Geurts, Timothy F. Cloughesy, Jason T. Huse +34 more

Towards consistency in pediatric brain tumor measurements: Challenges, solutions, and the role of artificial intelligence-based segmentation

Neuro-Oncology(2024)10.1093/neuonc/noae093

N/A

0DataRank · unranked

25 citations

Anahita Fathi Kazerooni, Arastoo Vossough, Jeffrey B. Ware, Sina Bagheri, Nastaran Khalili +16 more

Two decades of advances in clinical oncology — lessons learned and future directions

Nature Reviews Clinical Oncology(2024)10.1038/s41571-024-00945-4

N/A

0DataRank · unranked

23 citations

Christopher M. Booth, Éduardo Bruera, Markus W. Büchler, Alexander Drilon, Terry J. Fry +14 more

Long survival in a patient with fumarate hydratase mutation-associated glioma

Journal of Neuropathology & Experimental Neurology(2024)10.1093/jnen/nlae100

N/A

0DataRank · unranked

5 citations

Dorothee Gramatzki, Andrea Bink, Jürgen Hench, Stephan Frank, Martina Haberecker +6 more

CTNI-65. DETERMINANTS OF LONG-TERM SURVIVAL IN PATIENTS WITH IDH-MUTANT GLIOMAS

Neuro-Oncology(2024)10.1093/neuonc/noae165.0432

N/A

0DataRank · unranked

0 citations

Jonathan Weller, Sebastian Niedermeyer, Jens Blobner, Christoph Trumm, Rupert Egensperger +7 more

Update to the RANO working group and EANO recommendations for the clinical use of PET imaging in gliomas

The Lancet Oncology(2025)10.1016/s1470-2045(25)00193-7

N/A

0DataRank · unranked

30 citations

Philipp Lohmann, Mariam Aboian, Ramon Barajas, William G. Breen, Jana Ivanidze +29 more

A prognostic classification system for extent of resection in IDH-mutant grade 2 glioma: an international, multicentre, retrospective cohort study with external validation by the RANO resect group

The Lancet Oncology(2025)10.1016/s1470-2045(25)00534-0

N/A

0DataRank · unranked

17 citations

Jacob S. Young, Maarten M.J. Wijnenga, Tommaso Sciortino, Nico Teske, Alba Corell +44 more

RANO seizure working group-Tumor-Related Epilepsy Assessment Tool (RANO-TREAT) to assess seizure control for glioma treatment trials and clinical practice

Neuro-Oncology(2025)10.1093/neuonc/noaf165

N/A

0DataRank · unranked

4 citations

Anne S. Reiner, Terri S. Armstrong, Ashley Aaroe, Elizabeth Cunningham, Julia Brown +20 more

Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative

Neuro-Oncology(2025)10.1093/neuonc/noaf108

N/A

0DataRank · unranked

0 citations

Linda Dirven, Tobias Walbert, Terri S. Armstrong, David Arons, Martin J. van den Bent +24 more

Consensus recommendations for a dynamic susceptibility contrast MRI protocol for use in high-grade gliomas

Neuro-Oncology(2020)10.1093/neuonc/noaa141

N/A

0DataRank · unranked

195 citations

C. Chad Quarles, Leland Hu, Bradley J. Erickson, Elizabeth R. Gerstner, Marion Smits +26 more

cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas

Acta Neuropathologica(2020)10.1007/s00401-020-02127-9

N/A

0DataRank · unranked

535 citations

Kenneth Aldape, Howard Colman, Dominique Figrarella-Branger, Gregory N. Fuller, Caterina Giannini +15 more

PD-1 Inhibitors: Do they have a Future in the Treatment of Glioblastoma?

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1135

N/A

0DataRank · unranked

126 citations

David A. Reardon, Michael Weller, John H. Sampson, Mustafa Khasraw

CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design

Neuro-Oncology(2020)10.1093/neuonc/noaa168

N/A

0DataRank · unranked

116 citations

Karla V. Ballman, Martin J. van den Bent, Caterina Giannini, Evanthia Galanis, Paul D. Brown +18 more